 | Selegiline | IC50 | 19.6 [1] |
| Selegiline | Ki | 91.0 [1] |
 | Iproniazid | IC50 | 7540.0 [1] |
 | Clorgiline | IC50 | 61350.0 [1] |
 | Rasagiline | IC50 | 46.0 [1] |
| Rasagiline | Ki | 7.6 [1], 14.2 [2], 700.0 [3] |
 | Safinamide | IC50 | 23.07 [1] |
| Safinamide | Ki | 5.4 [1], 16.7 [2], 450.0 [3] |
 | Isatin | IC50 | 18750.0 [1] |
| Isatin | Ki | 3000.0 [1] |
 | Lazabemide | IC50 | 91.0 [1] |
| Lazabemide | Ki | 3.9 [1], 6.0 [2], 72.2 [3], 84.0 [4] |
 | Pargyline | IC50 | 188.0 [1] |
| Pargyline | Ki | 20.3 [1], 49.5 [2], 1800.0 [3] |
 | (1S,2R)-2-Phenylcyclopropan-1-amine;(1R,2S)-2-phenylcyclopropan-1-amine | IC50 | 3600.0 [1] |
| (1S,2R)-2-Phenylcyclopropan-1-amine;(1R,2S)-2-phenylcyclopropan-1-amine | Ki | 26.0 [1] |
 | Moclobemide | IC50 | 1000000.0 [1] |
| Moclobemide | Ki | 1340.0 [1] |
 | Parnate | IC50 | 3500.0 [1] |
| Parnate | Ki | 16000.0 [1] |
 | 8-(3-Chlorostyryl)caffeine | IC50 | 17.8 [1], 18.1 [2], 587.6 [3] |
| 8-(3-Chlorostyryl)caffeine | Ki | 70.0 [1], 80.6 [2], 86.0 [3], 210.0 [4], 235.0 [5] |
 | Ladostigil | IC50 | 37100.0 [1], 120000.0 [2] |
| Ladostigil | Ki | 213000.0 [1] |
 | Iadademstat | IC50 | 100000.0 [1] |
 | 6-[[4-(Trifluoromethyl)phenyl]methoxy]-3H-2-benzofuran-1-one | IC50 | 1.4 [1] |
| 6-[[4-(Trifluoromethyl)phenyl]methoxy]-3H-2-benzofuran-1-one | Ki | 0.46 [1], 0.6 [2], 0.7 [3] |
 | Pioglitazone | IC50 | 298.0 [1] |
| Pioglitazone | Ki | 199.4 [1], 270.8 [2], 500.0 [3] |
 | 5-Benzyloxyphthalimide | IC50 | 43.0 [1] |
| 5-Benzyloxyphthalimide | Ki | 19.0 [1] |
 | N-(4-Chlorophenyl)-4-oxochromene-3-carboxamide | IC50 | 2.9 [1], 8.0 [2], 63.0 [3], 63.1 [4] |
 | Phenelzine | IC50 | 143.0 [1] |
| Phenelzine | Ki | 94.0 [1], 124.0 [2] |
 | Mofegiline | IC50 | 5.0 [1], 10.0 [2] |
| Mofegiline | Ki | 28.0 [1] |
 | Tranylcypromine hydrochloride | IC50 | 35.0 [1], 2500.0 [2], 5900.0 [3] |
 | 4-(2-Pyridylazo)-N,N-dimethylaniline | IC50 | 140.0 [1] |
| 4-(2-Pyridylazo)-N,N-dimethylaniline | Ki | 70.0 [1] |
 | (E)-3-(4-Chlorophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one | IC50 | 4.4 [1], 4.47 [2], 4365.16 [3] |
 | (E)-3-(4-Hydroxybenzylidene)chroman-4-one | IC50 | 55.37 [1], 242.0 [2], 54954.09 [3] |
 | 3-Methyl-8-(4,4,4-trifluoro-butoxy)-indeno[1,2-c]pyridazin-5-one | IC50 | 0.01 [1] |
| 3-Methyl-8-(4,4,4-trifluoro-butoxy)-indeno[1,2-c]pyridazin-5-one | Ki | 280.0 [1], 14000.0 [2] |
 | 3,4-Dimethyl-7-(3,4-difluorobenzyloxy)coumarin | IC50 | 1.1 [1], 1.14 [2], 4.25 [3] |
 | N,N-Dimethyl-4-(pyridin-2-ylmethylideneamino)aniline | IC50 | 68.0 [1] |
| N,N-Dimethyl-4-(pyridin-2-ylmethylideneamino)aniline | Ki | 40.0 [1] |
 | 3-(4-Methoxyphenyl)-6-methyl-2H-chromen-2-one | IC50 | 13.05 [1] |
 | 6-Methyl-3-phenylchromen-2-one | IC50 | 283.75 [1] |
 | (E)-3-(3-Chlorophenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one | IC50 | 490.0 [1] |
| (E)-3-(3-Chlorophenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one | Ki | 294.0 [1] |
 | 7-(4-Fluorobenzyloxy)chroman-4-one | IC50 | 8.6 [1], 8.62 [2], 12.34 [3] |
 | 6-[(4-Chlorophenyl)methoxy]chromen-4-one | IC50 | 2.0 [1], 25.31 [2] |
 | (E)-3-(5-Chlorofuran-2-yl)-1-(3-chlorophenyl)prop-2-en-1-one | IC50 | 174.0 [1] |
| (E)-3-(5-Chlorofuran-2-yl)-1-(3-chlorophenyl)prop-2-en-1-one | Ki | 144.0 [1] |
 | 7-[(3-Bromophenyl)methoxy]-3,4-dihydro-1H-quinolin-2-one | IC50 | 2.9 [1], 8.17 [2] |
| 7-[(3-Bromophenyl)methoxy]-3,4-dihydro-1H-quinolin-2-one | Ki | 2.7 [1] |
 | 1-(4-(3-Fluorobenzyloxy)-2-hydroxyphenyl)ethanone | IC50 | 2.8 [1], 2.9 [2], 41.38 [3] |
 | 6-[(4-Chlorophenyl)methoxy]-1,3-benzoxathiol-2-one | IC50 | 3.0 [1] |
| 6-[(4-Chlorophenyl)methoxy]-1,3-benzoxathiol-2-one | Ki | 3.5 [1], 3.9 [2] |
 | 7-[[4-(Trifluoromethyl)phenyl]methoxy]chromen-4-one | IC50 | 8.0 [1], 27.82 [2] |
 | 8-[2-(4-Chlorophenyl)ethylsulfanyl]-1,3,7-trimethylpurine-2,6-dione | IC50 | 20.0 [1] |
| 8-[2-(4-Chlorophenyl)ethylsulfanyl]-1,3,7-trimethylpurine-2,6-dione | Ki | 9.8 [1], 13.0 [2] |
 | 4-N-[(1S,2R)-2-[4-[3-(Trifluoromethyl)phenyl]phenyl]cyclopropyl]cyclohexane-1,4-diamine | IC50 | 1840.0 [1], 2270.0 [2], 6650.0 [3] |
 | Caffeine | Ki | 3600000.0 [1], 3800000.0 [2] |
 | Quercetin | IC50 | 38660.0 [1], 90000.0 [2] |
 | 1,4-Benzoquinone | IC50 | 10200.0 [1] |
| 1,4-Benzoquinone | Ki | 20300.0 [1] |
 | Semicarbazide | IC50 | 6.7 [1], 6700.0 [2] |
 | Linezolid | IC50 | 2100.0 [1], 17000.0 [2] |
 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Ki | 280000.0 [1], 500000.0 [2] |
 | Rosiglitazone | IC50 | 832.0 [1] |
| Rosiglitazone | Ki | 4200.0 [1] |
 | Donepezil | IC50 | 15000.0 [1], 15200.0 [2] |
 | Apigenin | IC50 | 1120.0 [1], 12800.0 [2] |
 | Selegiline hydrochloride | IC50 | 6.59 [1], 6.79 [2] |
 | Deprenyl | IC50 | 19.0 [1], 19.6 [2] |
 | Troglitazone | IC50 | 2070.0 [1] |
| Troglitazone | Ki | 9500.0 [1] |
 | Tranylcypromine | IC50 | 2950.0 [1], 7000.0 [2] |
 | Chalcone | IC50 | 1410.0 [1], 1412537.54 [2] |
 | N-Propargyl-1(S)-aminoindan | IC50 | 14.0 [1] |
| N-Propargyl-1(S)-aminoindan | Ki | 127000.0 [1] |
 | Acacetin | IC50 | 49.0 [1] |
| Acacetin | Ki | 49.0 [1] |
 | 1H-Imidazole, 2-(2-benzofuranyl)-4,5-dihydro- | Ki | 8300.0 [1], 26000.0 [2] |
 | 5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione | IC50 | 13000.0 [1] |
 | N-(2-Aminoethyl)-4-chlorobenzamide | Ki | 32.2 [1], 996.9 [2] |
 | 2-(Phenylazo)pyridine | IC50 | 10000.0 [1] |
| 2-(Phenylazo)pyridine | Ki | 5300.0 [1] |
 | N-[(5-Phenylmethoxy-1H-indol-2-yl)methyl]prop-2-yn-1-amine | IC50 | 4.1 [1], 11.0 [2] |
 | CID 53378764 | IC50 | 39.0 [1], 1200.0 [2] |
 | trans,trans-1,4-Diphenyl-1,3-butadiene | Ki | 0.6 [1], 600.0 [2] |
 | 7-(Benzyloxy)-2H-chromen-2-one | IC50 | 1.7 [1], 3.8 [2] |
 | 3-(4-Chlorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one | IC50 | 160.0 [1], 158489.32 [2] |
 | (E)-N'-(1-(5-Chloro-2-hydroxyphenyl)ethylidene)-3-(morpholinosulfonyl)benzohydrazide | IC50 | 300000.0 [1] |
 | Hispidol | IC50 | 2450.0 [1] |
| Hispidol | Ki | 510.0 [1] |
 | 7-Benzyloxy-4-methyl-chromen-2-one | IC50 | 1.58 [1], 2.0 [2] |
 | 1,4-Naphthalenedione, 2,3,6-trimethyl- | Ki | 3000.0 [1], 6000.0 [2] |
 | (E)-3-(2,4-Dimethoxybenzylidene)chroman-4-one | IC50 | 247.51 [1], 245470.89 [2] |
Calculator
